| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b71b52e0e0dd497f4158bb1a6deee616 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4715 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
1997-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0c6282b6842a1e199228fab2aedac40 |
| publicationDate |
1999-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0937254-A2 |
| titleOfInvention |
METHOD FOR THE INDIRECT DETERMINATION OF THE IN VIVO PRODUCTION OF INTERFERON OF TYPE I BY MEANS OF ANTIBODIES DIRECTED AGAINST Mx HUMAN PROTEINS |
| abstract |
The invention provides methods of indirectly measuring the level of type I interferons in vivo utilizing antibodies directed against MxA and/or MxB. The methods find application in conjunction with therapies directed to raising or lowering the levels of interferons in patients. Also provided are new monoclonal antibodies that recognize specific human Mx protein(s). |
| priorityDate |
1996-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |